The Long-Term Prognosis of PrEP


HIV Stakeholders weigh on the future of PrEP.

Video Highlights

1:11 Gary Spinner, DMSc, PA, MPH, AAHIVS

3:46 Randy Matthews, PhD, MD

4:52 Carl Schmid

Welcome to our series, 1 Big Question, which asks 1 question to the medical community and we get their feedback on an important infectious disease topic.

In this episode, our 1 Big Question is: Will PrEP have a prominent role and significant impact in HIV prevention?

We interviewed Gary Spinner, DMSc, PA, MPH, AAHIVS, medical director of the HIV/AIDS Program, Southwest Community Health Center, Randy Matthews, PhD, MD, senior principal scientist, Merck, and Carl Schmid, executive director, HIV+Hepatitis Policy Institute.

Check out our video to hear their insights.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.